Abstract:The clinical interpretation of missense variants is critically important in diagnostics due to their potential to cause mild-to-severe effects on phenotype by altering protein structure. Evaluating these variants is essential because they can significantly impact disease outcomes and patient management. Many computational predictors, known as in silico pathogenicity predictors (ISPPs), have been developed to support the assessment of variant pathogenicity. Despite the abundance of these ISPPs, their predictions often lack accuracy and consistency, primarily due to limited data availability and the presence of erroneous data. This inconsistency can lead to false positive or negative results in pathogenicity evaluation, highlighting the need for standardization. The necessity for reliable evaluation methods has driven the development of numerous ISPPs, each attempting to address different aspects of variant interpretation. However, the sheer number of ISPPs and their varied performances make it challenging to achieve consensus in predictions. Therefore, a comprehensive statistical approach to evaluate and integrate these predictors is essential to improve accuracy. Here, we present a comprehensive statistical analysis comparing 52 available ISPPs, which aims to enhance the precision of variant classification. Our work introduces the Variant Analysis with Multiple Pathogenicity Predictors-score (VAMPP-score), a novel statistical framework designed for the assessment of missense variants. The VAMPP-score leverages the best gene-ISPP matches based on ISPP accuracies, providing a combinatorial weighted score that improves missense variant interpretation. We chose to develop a statistical framework rather than creating a new ISPP to capitalize on the strengths of existing predictors and to address their limitations through an integrative approach. This approach not only improves the evaluation of missense variants but also offers a flexible statistical framework designed to identify and utilize the best-performing ISPPs. By enhancing the accuracy of genetic diagnostics, particularly in the reanalysis of rare and undiagnosed cases, our framework aims to improve patient outcomes and advance the field of genetic research.

A Novel Statistical Method for Interpreting the Pathogenicity of Rare Variants

Improved Detection of Rare Genetic Variants for Diseases

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

REVEL: an Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

Comparing Sequence-Based and Literature-Based Pathogenicity Scoring Methods for Human Variants

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort

A Novel Method, the Variant Impact on Linkage Effect Test (VIOLET), Leads to Improved Identification of Causal Variants in Linkage Regions

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases

Sequence-Based Prioritization of Nonsynonymous Single-Nucleotide Polymorphisms for the Study of Disease Mutations

Leveraging cancer mutation data to predict the pathogenicity of germline missense variants

When a "Disease-Causing Mutation" is Not a Pathogenic Variant.

Prioritization of Candidate Nonsynonymous Single Nucleotide Polymorphisms via Sequence Conservation Features

BETASEQ: a Powerful Novel Method to Control Type-I Error Inflation in Partially Sequenced Data for Rare Variant Association Testing.

A Method for Predicting Allelic Variants of Single Nucleotide Polymorphisms

Statistics to prioritize rare variants in family-based sequencing studies with disease subtypes

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Lab

Integrative Analysis of Sequencing and Array Genotype Data for Discovering Disease Associations with Rare Mutations

A New Era in Missense Variant Analysis: Statistical Insights and the Introduction of VAMPP-Score for Pathogenicity Assessment

A Sequence-Based Method to Predict the Impact of Regulatory Variants Using Random Forest.